IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia

References

• Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230):1146–1162. doi:10.1016/S0140-6736(19)33018-1
   PubMed Web of Science ®Google Scholar
• Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577. doi:10.1038/bcj.2017.53
   PubMed Web of Science ®Google Scholar
• Abdalhabib EK, Alzahrani B, Alanazi F, et al. Increased risk of acute lymphoblastic leukemia in adult patients with GSTM1 null genetic polymorphism. Pharmgenomics Pers Med. 2022;15:227–234. doi:10.2147/pgpm.s356302
   PubMed Web of Science ®Google Scholar
• Mikami T, Kato I, Wing JB, et al. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia. Cancer Sci. 2022;113(1):41–52. doi:10.1111/cas.15186
   PubMed Web of Science ®Google Scholar
• Saraiva M, Saraiva M, Vieira P, et al. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1):1–19. doi:10.1084/jem_20190418
   PubMed Web of Science ®Google Scholar
• Naing A, Papadopoulos KP, Autio KA, et al. Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors. J Clin Oncol. 2016;34(29):3562–3569. doi:10.1200/JCO.2016.68.1106
   PubMed Web of Science ®Google Scholar
• Sun L, Cornell TT, LeVine A, et al. Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin Exp Immunol. 2013;172(2):263–279. doi:10.1111/cei.12059
   PubMed Web of Science ®Google Scholar
• Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-γin tumor progression and regression: a review. Biomark Res. 2020;8(1):1–16. doi:10.1186/s40364-020-00228-x
   PubMed Web of Science ®Google Scholar
• Ross SH, Cantrell DA. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36(1):411–433. doi:10.1146/annurev-immunol-042617-053352
   PubMed Web of Science ®Google Scholar
• Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr. 2007;137(1):194S–199S. doi:10.1093/jn/137.1.194S
   PubMed Web of Science ®Google Scholar
• Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871–891. doi:10.1016/j.immuni.2019.03.020
   PubMed Web of Science ®Google Scholar
• Lech-Maranda E, Baseggio L, Bienvenu J, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood. 2004;103(9):3529–3534. doi:10.1182/blood-2003-06-1850
   PubMed Web of Science ®Google Scholar
• Sarris AH, Kliche KO, Pethambaram P, et al. Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival. Ann Oncol off J Eur Soc Med Oncol. 1999;10(4):433–440. doi:10.1023/a:1008301602785
   PubMed Web of Science ®Google Scholar
• Stewart JP, Behm FG, Arrand JR, Rooney CM. Differential expression of viral and human Interleukin-10 (IL-10) by Primary B cell tumors and B cell lines. Virology. 1994;200(2):724–732. doi:10.1006/viro.1994.1236
   PubMed Web of Science ®Google Scholar
• Hiroki CH, Amarante MK, Petenuci DL, et al. IL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients IL-10 polymorphism and plasma levels in leukemia patients. Blood Cells, Mol Dis. 2015;55(2):168–172. doi:10.1016/j.bcmd.2015.06.004
   PubMed Web of Science ®Google Scholar
• de Oliveira JG, Rossi AFT, Nizato DM, et al. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2015;36(12):9159–9170. doi:10.1007/s13277-015-3593-x
   PubMedGoogle Scholar
• Niu Y-M, Du X-Y, Cai H-X, et al. Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis. Sci Rep. 2015;5:17149. doi:10.1038/srep17149
   PubMed Web of Science ®Google Scholar
• Stanczuk GA, Sibanda EN, Perrey C, et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer. 2001;94(6):792–794. doi:10.1002/ijc.1543
   PubMed Web of Science ®Google Scholar
• Pratap PD, Raza ST, Zaidi G, et al. Genetic variants in Interleukin-10 gene association with susceptibility and cervical cancer development: a case control study. Glob Med Genet. 2022;9:129–140. doi:10.1055/s-0042-1743262
   PubMedGoogle Scholar
• Pehlivan M, Sahin HH, Pehlivan S, et al. Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid Leukemia. Genet Test Mol Biomarkers. 2014;18(6):403–409. doi:10.1089/gtmb.2014.0011
   PubMed Web of Science ®Google Scholar
• Yao C-J, Du W, Chen H-B, Xiao S, Wang C-H, Fan Z-L. Associations of IL-10 gene polymorphisms with acute myeloid leukemia in Hunan, China. Asian Pac J Cancer Prev. 2013;14(4):2439–2442. doi:10.7314/apjcp.2013.14.4.2439
   PubMedGoogle Scholar
• Sharif OM, Hassan R, Basbaeen AAM, Mohmed AH, Ibrahim IK. Interleukin-10 (1082G/A) polymorphism is associated with susceptibility of acute myeloid leukemia patients in Sudanese Population. Asian Pacific J Cancer Prev. 2019;20(7):1939–1943. doi:10.31557/APJCP.2019.20.7.1939
   PubMedGoogle Scholar
• Fei C, Yao XM, Sun Y, Gu XZ, Yu LQ, Lai X. Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia. Genet Mol Res. 2015;14(1):925–930. doi:10.4238/2015.February.2.15
   PubMed Web of Science ®Google Scholar
• Bănescu C, Tripon F, Trifa AP, et al. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia. Cancer Med. 2019;8(12):5492–5506. doi:10.1002/cam4.2424
   PubMed Web of Science ®Google Scholar
• Hong P, Feng W, Fu L, Jin J, Fu J. Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis. Cancer Biol Ther. 2020;21(4):372–378. doi:10.1080/15384047.2019.1702404
   PubMed Web of Science ®Google Scholar
• Li G, Li D. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: a meta-analysis. Hum Immunol. 2016;77(5):418–425. doi:10.1016/j.humimm.2016.03.006
   PubMed Web of Science ®Google Scholar
• Lo WJ, Chang WS, Hsu HF, et al. Significant association of Interleukin-10 polymorphisms with childhood leukemia susceptibility in Taiwan. Vivo. 2016;30(3):265–269.
   PubMed Web of Science ®Google Scholar
• Zhu ZY, Liu J-B, Liu X, Qian LX. Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis. J Int Med Res. 2020;48(4):030006052090486. doi:10.1177/0300060520904863
   Web of Science ®Google Scholar
• Trifunović J, Miller L, Debeljak Ž, Horvat V. Pathologic patterns of interleukin 10 expression - A review. Biochem Medica. 2015;25(1):36–48. doi:10.11613/BM.2015.004
   PubMed Web of Science ®Google Scholar
• Brockmann L, Giannou AD, Gagliani N, Huber S. Regulation of T(H)17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis. Int J Mol Sci. 2017;18(5):1033. doi:10.3390/ijms18051033
   PubMed Web of Science ®Google Scholar
• Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur J Endocrinol. 2015;172(4):403–413. doi:10.1530/EJE-14-0837
   PubMed Web of Science ®Google Scholar
• Wu J, Huang Q, Meng D, Huang M, Li C, Qin TA. Functional rs353293 polymorphism in the promoter of miR-143/145 is associated with a reduced risk of bladder cancer. PLoS One. 2016;11(7):e0159115. doi:10.1371/journal.pone.0159115
   PubMed Web of Science ®Google Scholar
• Winkler B, Taschik J, Haubitz I, Eyrich M, Schlegel PG, Wiegering V. TGFβ and IL10 have an impact on risk group and prognosis in childhood ALL. Pediatr Blood Cancer. 2015;62(1):72–79. doi:10.1002/pbc.25142
   PubMed Web of Science ®Google Scholar
• de Deus DMV, Lugo KA, Muniz MTC. Influence of IL10 (G1082A) and TNF α (G308A) polymorphisms on the survival of pediatric patients with ALL. Leuk Res Treatment. 2012;2012:1–6. doi:10.1155/2012/692348
   Google Scholar
• Gao S, Tang K, Chen J, Wang J. The single nucleotide polymorphisms of interleukin-10 are associated with the risk of leukaemia: evidence from 18 case-control studies. Medicine. 2020;99(44):e23006. doi:10.1097/MD.0000000000023006
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Abdo N, Al-Eitan LN, Al-Mistarehi AH, Zahran DJ, Kewan TZ. The impact of IL-6 and IL-10 gene polymorphisms in diffuse large B-cell lymphoma risk and overall survival in an Arab population: a case-control study. Cancers. 2020;12(2):1–11. doi:10.3390/cancers12020382
   Web of Science ®Google Scholar
• Domingo-Domènech E, Benavente Y, González-Barca E, et al. Impact of interleukin-10 polymorphisms (−1082 and −3575) on the survival of patients with lymphoid neoplasms. Haematologica. 2007;92(11):1475–1481. doi:10.3324/haematol.11350
   PubMed Web of Science ®Google Scholar
• Gaiolla RD, de Toledo Moraes MP, de Oliveira DE. SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma. PLoS One. 2021;16:1–15. doi:10.1371/journal.pone.0248259
   Web of Science ®Google Scholar